Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTK | Q06187 | 17/20 | 0.69 |
| ▸ | CD69 | Q07108 | 2/20 | 0.69 |
| ▸ | AAK1 | Q2M2I8 | 2/20 | 0.69 |
| ▸ | JAK2 | O60674 | 1/20 | 0.69 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.69 |
| ▸ | HRH2 | P25021 | 1/20 | 0.69 |
| ▸ | CDK7 | P50613 | 1/20 | 0.69 |
| ▸ | MAP3K19 | Q56UN5 | 1/20 | 0.69 |
| ▸ | CDKL2 | Q92772 | 1/20 | 0.69 |
| ▸ | RIOK1 | Q9BRS2 | 1/20 | 0.69 |
| ▸ | RIOK2 | Q9BVS4 | 1/20 | 0.69 |
| ▸ | BMP2K | Q9NSY1 | 1/20 | 0.69 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.37 |
| ▸ | CYP2J2 | P51589 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16794224 | 1.00 | BTK (0.69) | BTKCD69AAK1JAK2CYP3A4 | |
| SCHEMBL28881293 | 0.89 | BTK (0.69) | BTKCD69AAK1JAK2CYP3A4 | |
| SCHEMBL29986746 | 0.89 | BTK (0.69) | BTKCD69AAK1JAK2CYP3A4 | |
| SCHEMBL16814060 | 0.88 | BTK (0.54) | BTKCD69AAK1JAK2CYP3A4 | |
| SCHEMBL20461055 | 0.86 | BTK (0.61) | BTKCD69AAK1JAK2CYP3A4 | |
| SCHEMBL29676771 | 0.85 | BTK (0.59) | BTKCD69AAK1JAK2CYP3A4 | |
| SCHEMBL16793760 | 0.85 | BTK (0.59) | BTKCD69AAK1JAK2CYP3A4 | |
| SCHEMBL25169920 | 0.85 | BTK (0.51) | BTKCD69AAK1JAK2CYP3A4 | |
| SCHEMBL30913579 | 0.84 | BTK (0.52) | BTKCD69AAK1JAK2CYP3A4 | |
| SCHEMBL25176696 | 0.84 | BTK (0.52) | BTKCD69AAK1JAK2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4428130-A1 | COMPOUND HAVING BTK PROTEIN DEGRADATION ACTIVITY, AND MEDICAL USES THEREOF | Ubix Therapeutics, Inc. (KR) | 2024-09-11 | — | — | EP | disclosed |
| CN-118159532-A | Compound with BTK protein degradation activity and medical application thereof | 尤比克斯治疗公司 | 2024-06-07 | — | — | CN | disclosed |
| WO-2023183652-A1 | DUAL CXCR4-BTK INHIBITORS | X4 PHARMACEUTICALS, INC. (US) | 2023-09-28 | — | — | WO | disclosed |
| CN-109096274-B | Biaryl compounds useful in the treatment of human oncological, neurological and immunological diseases | 比奥根MA公司 | 2022-07-01 | — | — | CN | disclosed |